CompletedNCT01072617
Cerebellar rTMS for schizophrenia
About this title
Read the official source — NCT01072617This study evaluated the safety and effectiveness of transcranial magnetic stimulation for people with schizophrenia.
Device studyAges 18–65United States
Understand this study
What did researchers investigate?
This study evaluated the safety and effectiveness of transcranial magnetic stimulation for people with schizophrenia.
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- BostonSee all locations and recruitment
Study information
Study start dateFebruary 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 8
- Sponsor
- Beth Israel Deaconess Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Device
- Intervention type
- Device
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01072617
- Official title
Show the full official title
Safety and Therapeutic Efficacy of Cerebellar Repetitive Transcranial Magnetic Stimulation in Patients With Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Boston
Interested in joining this study?
Questions about this study
What did researchers investigate?
This study evaluated the safety and effectiveness of transcranial magnetic stimulation for people with schizophrenia.
Who is behind this study?
The study sponsor is Beth Israel Deaconess Medical Center, a hospital or academic medical center.
Who was this study for?
Listed age limits: 18 years to 65 years.
